Hypoglycemia surgery

Hypoglycemia Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hypoglycemia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic criteria
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hypoglycemia surgery On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hypoglycemia surgery All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hypoglycemia surgery
CDC on Hypoglycemia surgery
Hypoglycemia surgery in the news
Blogs on Hypoglycemia surgery
Directions to Hospitals Treating Hypoglycemia
Risk calculators and risk factors for Hypoglycemia surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Mohammed Abdelwahed M.D[2]

Overview

Surgical removal of the insulinoma is the treatment of choice and resection of metastatic liver disease.

Surgery

• Surgical removal of the insulinoma is the treatment of choice:
• Enucleation of the insulinoma
• Partial distal pancreatectomy
• Distal subtotal pancreatectomy is recommended for patients with insulinoma related to MEN1.
• Recurrence is more common in the patients with MEN1.
• Hepatic resection is indicated for the treatment of metastatic liver disease if general condition is good. Resection should be considered only for patients with a limited number of hepatic metastases.